[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 4,498
Sort by:
Basal cell carcinoma - Pipeline Insight, 2021 US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Basal Cell Carcinoma (Basal Cell Epithelioma) The report also ...

October 2021 70 pages
Chondrosarcoma - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Chondrosarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chondrosarcoma development. The report provides detailed ...

October 2021 60 pages
Binge-eating disorder - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Binge Disorders - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Binge Disorders development. The report provides ...

October 2021 60 pages
Herpes labialis - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Herpes Labialis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Herpes Labialis development. The report provides ...

October 2021 60 pages
Hypertriglyceridemia - Pipeline Insight, 2021 US$ 2,000.00

... clients within 48 Hours 'Hypertriglyceridemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hypertriglyceridemia development. The report provides detailed ...

October 2021 60 pages
Liposarcoma - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Liposarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Liposarcoma development. The report provides detailed ...

October 2021 60 pages
Medulloblastoma - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Medulloblastoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Medulloblastoma development. The report provides detailed ...

October 2021 60 pages
Myelofibrosis - Pipeline Insight, 2021 US$ 2,000.00

... clients within 48 Hours 'Myelofibrosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Myelofibrosis development. The report provides detailed ...

October 2021 80 pages
Peptic Ulcer - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Peptic Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Peptic Ulcers development. The report provides ...

October 2021 60 pages
Pulmonary Embolism - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Pulmonary Embolism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pulmonary Embolism development. The report provides ...

October 2021 60 pages
Rosacea - Pipeline Insight, 2021 US$ 2,000.00

... clients within 48 Hours 'Rosacea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rosacea development. The report provides detailed ...

October 2021 60 pages
Narcolepsy - Pipeline Insight, 2021 US$ 1,500.00

... Narcolepsy - Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Narcolepsy. A detailed picture of the pipeline ... and Discontinued) Overview of pipeline development activities for Narcolepsy Pipeline analysis of therapeutic drugs include ...

October 2021 60 pages
Ataxia-telangiectasia - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Ataxia-telangiectasia - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipelin...

October 2021 60 pages
Beta-thalassaemia - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Beta-thalassaemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+...

October 2021 60 pages
Bullous pemphigoid - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Bullous pemphigoid - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ p...

October 2021 60 pages
Carcinoid Syndrome - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Carcinoid Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...

October 2021 60 pages
Fibrodysplasia ossificans progressiva - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 72 hours DelveInsight’s, “Fibrodysplasia ossificans progressiva - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ compani...

October 2021 60 pages
Gaucher’s Disease - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Gaucher’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 14+ companies and 16+ pipeline...

October 2021 60 pages
Lyme Disease - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 72 hours DelveInsight’s, “Lyme Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs i...

October 2021 60 pages
Muscle Spasticity - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Muscle Spasticity – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline dr...

October 2021 60 pages
Neurofibromatosis - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Neurofibromatosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...

October 2021 60 pages
Presbyopia - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Presbyopia - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs i...

October 2021 60 pages
Primary Ciliary Dyskinesia - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Primary Ciliary Dyskinesia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pi...

October 2021 60 pages
Chronic Rhinosinusitis - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic Rhinosinusitis - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...

October 2021 60 pages
Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Inflammation and Pain Post Cataract Surgery – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ co...

October 2021 60 pages
Keloids - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Keloids - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Kel...

October 2021 60 pages
Ocular Inflammation and Pain - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Ocular Inflammation and Pain – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...

October 2021 60 pages
Hemochromatosis - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Hemochromatosis – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drug...

October 2021 60 pages
Immune Thrombocytopenic Purpura - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Immune Thrombocytopenic Purpura - Pipeline Insight, 2021,” report provides comprehensive insights about 18+ companies and...

October 2021 60 pages
Osteonecrosis - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Osteonecrosis – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs...

October 2021 60 pages
Peritoneal Cancer - Pipeline Insight, 2021 US$ 2,500.00

This report can be delivered to the clients within 5-6 business days DelveInsight’s, “Peritoneal cancer – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+...

October 2021 60 pages
Recurrent anaplastic astrocytomas - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Recurrent anaplastic astrocytomas – Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies an...

October 2021 60 pages
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Antisense Oligonucleotide Therapeutics – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ com...

October 2021 60 pages
TIL therapy - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “TIL therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 20+ pipeline dru...

October 2021 60 pages
Acute Graft-versus-Host Disease - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Acute Graft-versus-Host Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and...

October 2021 60 pages
Chikungunya virus infections - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Chikungunya virus infections - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10...

October 2021 60 pages
Medical Marijuana - Cannabidiol – Pipeline Insight, 2021 US$ 2,500.00

This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Medical Marijuana - Cannabidiol – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ comp...

October 2021 60 pages
Mucosa-associated Lymphoid Tissue (MALT) Lymphoma - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Mucosa-associated Lymphoid Tissue (MALT) Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights about...

October 2021 60 pages
Natural Killer Cell Therapies - Pipeline Insight, 2021 US$ 3,000.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight’s, “Natural Killer Cell Therapies - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ comp...

October 2021 300 pages
Stomatitis - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Stomatitis – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drug...

October 2021 60 pages
T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “T-Cell Acute Lymphoblastic Leukemia – Pipeline Insight, 2021,” report provides comprehensive insights about 12+ compan...

October 2021 60 pages
TCR therapy - Pipeline Insight, 2021 US$ 2,000.00

This report can be delivered to the clients within 3-5 business days DelveInsight’s, “TCR therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 35+ pipeli...

October 2021 60 pages
Zika Virus Infection - Pipeline Insight, 2021 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Zika Virus Infection - Pipeline Insight, 2021,” report provides comprehensive insights about 12+ companies and 12+ pipeli...

October 2021 60 pages
Critical Limb Ischemia - Pipeline Insight, 2021 US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Critical Limb Ischemia The report also ...

September 2021 60 pages
Hepatitis A - Pipeline Insight, 2021 US$ 1,500.00

... clients within 48 Hours 'Hepatitis A - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatitis A development. The report provides ...

September 2021 60 pages
Leber hereditary optic neuropathy - Pipeline Insight, 2021 US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Leber's Hereditary Optic Neuropathy The report also ...

September 2021 60 pages
Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2021 US$ 2,000.00

... not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Acetylcholine Receptor (AChR) Antagonist The report ...

September 2021 80 pages
Adenosine Antagonists - Pipeline Insight, 2021 US$ 2,000.00

... not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Adenosine Antagonist The report assesses ...

September 2021 90 pages
Adrenergic Antagonists - Pipeline Insight, 2021 US$ 2,000.00

... not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Adrenergic Antagonist The report assesses ...

September 2021 90 pages
Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2021 US$ 2,000.00

... not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Brutons Tyrosine Kinase (Btk) Inhibitor The report ...

September 2021 100 pages

Filters

Search

Categories

231
9
3,237
667
354

Publishers

4,498

Regions

4,498

Price

Date

Pages

Offers